相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activation of the Bone Morphogenetic Protein Receptor by H11Kinase/Hsp22 Promotes Cardiac Cell Growth and Survival
Xiangzhen Sui et al.
CIRCULATION RESEARCH (2009)
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts
Mitsutoshi Asai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Cardiovascular Complications of Cancer Therapy Incidence, Pathogenesis, Diagnosis, and Management
Edward T. H. Yeh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Contrasting Proteome Biology and Functional Heterogeneity of the 20 S Proteasome Complexes in Mammalian Tissues
Aldrin V. Gomes et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Proteasome inhibition promotes regression of left ventricular hypertrophy
William E. Stansfield et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload
Nadia Hedhli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Hypertrophic cardiomyopathy in high-fat diet-induced obesity: role of suppression of forkhead transcription factor and atrophy gene transcription
Cindy X. Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome
Jinbao Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Proteasome inhibition and stress compromise the heart in chemotherapy
Yolande E. A. Appelman et al.
CARDIOVASCULAR RESEARCH (2008)
Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition
Hai Ying Fu et al.
CARDIOVASCULAR RESEARCH (2008)
Suppression of cardiomyocyte hypertrophy by inhibition of the ubiquitin-proteasome system
Silke Meiners et al.
HYPERTENSION (2008)
Acute severe cardiac failure in a myeloma patient due to proteasome inhibitor bortezomib
Abdullah Hacihanefioglu et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Upregulation of myocardial 11 S-activated proteasome in experimental hyperglycemia
Saul R. Powell et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Marked differences between atrial and ventricular gene-expression remodeling in dogs with experimental heart failure
Sophie Cardin et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
Proteasome inhibitors: Poison's and remedies
Silke Meiners et al.
MEDICINAL RESEARCH REVIEWS (2008)
The immune system and cardiac repair
Nikolaos G. Frangogiannis
PHARMACOLOGICAL RESEARCH (2008)
Proteasome activation during cardiac hypertrophy by the chaperone H11 Kinase/Hsp22
Nadia Hedhli et al.
CARDIOVASCULAR RESEARCH (2008)
Global changes to the ubiquitin system in Huntington's disease
Eric J. Bennett et al.
NATURE (2007)
Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury
William E. Stansfield et al.
ANNALS OF THORACIC SURGERY (2007)
Mechanism of attenuation of angiotensin-II-induced protein degradation by insulin-like growth factor-I (IGF-I)
Steven T. Russell et al.
CELLULAR SIGNALLING (2007)
Myocardial extracellular matrix remodeling in ischemic heart failure
Gabrielle L. Gallagher et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Exploring proteasome complexes by proteomic approaches
Oliver Drews et al.
PROTEOMICS (2007)
Heart failure and protein quality control
Xuejun Wang et al.
CIRCULATION RESEARCH (2006)
IκB kinase complexes:: gateways to NF-κB activation and transcription
Claus Scheidereit
ONCOGENE (2006)
Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy
Christophe Depre et al.
CIRCULATION (2006)
Endoplasmic reticulum stress signaling in disease
Stefan J. Marciniak et al.
PHYSIOLOGICAL REVIEWS (2006)
Cotranslocational degradation protects the stressed endoplasmic reticulum from protein overload
Seiichi Oyadomari et al.
CELL (2006)
Potential roles for ubiquitin and the proteasome during ribosome biogenesis
Diana A. Stavreva et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The ubiquitin-proteasome system in cardiac physiology and pathology
Saul R. Powell
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Esther A. Obeng et al.
BLOOD (2006)
Severe reversible cardiac failure after bortezomib treatment combined with chemotherapy in a non-small cell lung cancer patient: a case report
Jens Voortman et al.
BMC CANCER (2006)
Importance of the different proteolytic sites of the proteasome and the efficacy of inhibitors varies with the protein substrate
AF Kisselev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Adenoviral PR39 improves blood flow and myocardial function in a pig model of chronic myocardial ischemia by enhancing collateral formation
MJ Post et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Depression of proteasome activities during the progression of cardiac dysfunction in pressure-overloaded heart of mice
O Tsukamoto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
H11 kinase prevents myocardial infarction by preemptive preconditioning of the heart
C Depre et al.
CIRCULATION RESEARCH (2006)
Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis
ST Nawrocki et al.
CANCER RESEARCH (2005)
Saccharomyces cerevisiae Ub-conjugating enzyme Ubc4 binds the proteasome in the presence of translationally damaged proteins
SM Chuang et al.
GENETICS (2005)
Angiotensin II directly induces muscle protein catabolism through the ubiquitin-proteasome proteolytic pathway and may play a role in cancer cachexia
PM Sanders et al.
BRITISH JOURNAL OF CANCER (2005)
Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice
S Matsumura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Heart-directed expression of a human cardiac isoform of cAMP-response element modulator in transgenic mice
FU Müller et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Muscle-specific expression of IGF-1 blocks angiotensin II-induced skeletal muscle wasting
YH Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Mobilizing the proteolytic machine: cell biological roles of proteasome activators and inhibitors
M Rechsteiner et al.
TRENDS IN CELL BIOLOGY (2005)
Proteasome-mediated degradation of cotranslationally damaged proteins involves translation elongation factor 1A
SM Chuang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Myocardial hypertrophy of normotensive Wistar-Kyoto rats
EA Aiello et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I
V Kedar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload
JR McMullen et al.
CIRCULATION (2004)
Downregulation of matrix metalloproteinases and collagens and suppression of cardiac fibrosis by inhibition of the proteasome
S Meiners et al.
HYPERTENSION (2004)
Common genomic response in different mouse models of β-adrenergic-induced cardiomyopathy
V Gaussin et al.
CIRCULATION (2003)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Proline- and arginine-rich peptides constitute a novel class of allosteric inhibitors of proteasome activity
M Gaczynska et al.
BIOCHEMISTRY (2003)
Inducible cAMP early repressor (ICER) is a negative-feedback regulator of cardiac hypertrophy and an important mediator of cardiac myocyte apoptosis in response to β-adrenergic receptor stimulation
H Tomita et al.
CIRCULATION RESEARCH (2003)
Rapamycin attenuates load-induced cardiac hypertrophy in mice
T Shioi et al.
CIRCULATION (2003)
Proteasome inhibition ablates activation of NF-κB in myocardial reperfusion and reduces reperfusion injury
J Pye et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2003)
Progression from compensated hypertrophy to failure in the pressure-overloaded human heart -: Structural deterioration and compensatory mechanisms
S Hein et al.
CIRCULATION (2003)
Hyperubiquitination of proteins in dilated cardiomyopathy
J Weekes et al.
PROTEOMICS (2003)
Regulation of myocardial fibrillar collagen by angiotensin II.: A role in hypertensive heart disease?
A González et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
H11 kinase is a novel mediator of myocardial hypertrophy in vivo
C Depre et al.
CIRCULATION RESEARCH (2002)
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
RZ Orlowski et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Lower risk of postinfarct rupture in mouse heart overexpressing β2-adrenergic receptors:: Importance of collagen content
XM Gao et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Interaction of the eukaryotic elongation factor 1A with newly synthesized polypeptides
Y Hotokezaka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
β-blocker therapy in heart failure -: Scientific review
JM Foody et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress
G Esposito et al.
CIRCULATION (2002)
Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
MD Gomes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Identification of ubiquitin ligases required for skeletal muscle atrophy
SC Bodine et al.
SCIENCE (2001)
Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion
AL Bulteau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inhibition of ubiquitin-proteasome pathway-mediated IκBα degradation by a naturally occurring antibacterial peptide
YH Gao et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Cell cycle-regulated modification of the ribosome by a variant multiubiquitin chain
J Spence et al.
CELL (2000)
Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
U Schubert et al.
NATURE (2000)
PR39, a peptide regulator of angiogenesis
J Li et al.
NATURE MEDICINE (2000)
The proteasome activator 11 S REG (PA28) and Class I antigen presentation
M Rechsteiner et al.
BIOCHEMICAL JOURNAL (2000)
分享论文
